Immune correlates of protection by vaccine against SARS‐CoV‐2 in patients with chronic lymphocytic leukaemia

In chronic lymphocytic leukaemia (CLL) the efficacy of SARS‐CoV‐2 vaccination remains unclear as most studies have focused on humoral responses. Here we comprehensively examined humoral and cellular responses to vaccine in CLL patients. Seroconversion was observed in 55.2% of CLL with lower rate and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sorcini, Daniele, De Falco, Filomena, Gargaro, Marco, Bozza, Silvia, Guarente, Valerio, Cardinali, Valeria, Stella, Arianna, Adamo, Francesco Maria, Silva Barcelos, Estevao Carlos, Rompietti, Chiara, Dorillo, Erica, Geraci, Clelia, Esposito, Angela, Arcaleni, Roberta, Capoccia, Silvia, Mameli, Maria Grazia, Graziani, Alessandro, Moretti, Lorenzo, Cipiciani, Alessandra, Riccardi, Carlo, Mencacci, Antonella, Fallarino, Francesca, Rosati, Emanuela, Sportoletti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878216/
https://www.ncbi.nlm.nih.gov/pubmed/36484163
http://dx.doi.org/10.1111/bjh.18602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878216/
https://www.ncbi.nlm.nih.gov/pubmed/36484163
http://dx.doi.org/10.1111/bjh.18602

Ejemplares similares